Company: DVAX
Filing Date: 2025-04-03
Form Type: PREC14A
Source: 0000930413-25-001153
Chunk: 123

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-04-03
Form: PREC14A
Chunk 123
---
 the SEC by reason of their position
as directors of the Company or because they may be soliciting proxies on the Company’s behalf (collectively, the “Participants”).

Directors

The principal occupations of our directors,
other than Ms. Phillips and Ms. Eastland who will be retiring from the Board effective immediately prior to the Annual Meeting,
are described in the section titled “Election of Directors.” The names of our directors are below. The business address
of each of the directors is 2100 Powell Street, Suite 720 Emeryville, California 94608.

| Name                   |                        |                          |
| Scott Myers            | Daniel L. Kisner, M.D. | Lauren Silvernail        |
| Francis R. Cano, Ph.D. | Brent MacGregor        | Elaine Sun               |
| Julie Eastland         | Ryan Spencer           | Peter R. Paradiso, Ph.D. |
| Emilio Emini, Ph.D.    | Peggy V. Phillips      |                          |

Officers and Employees

The principal occupations of our executive
officers and employees who are considered Participants are set forth below. The principal occupation refers to such person’s
position with the Company and the business address for each person is 2100 Powell Street, Suite 720 Emeryville, California 94608.

| Name            | Title                                          |
| Ryan Spencer    | Chief Executive Officer and Director           |
| Kelly MacDonald | Senior Vice President, Chief Financial Officer |
| John L. Slebir  | Senior Vice President, General Counsel         |

Information Regarding Ownership of the Company’s Securities by Participants

The number of shares of common stock held
as of March 14, 2025 by the Participants who are directors or executive officers is set forth in the section titled “Security
Ownership of Certain Beneficial Owners and Management” of this proxy statement.

The following table sets forth the number
of shares of common stock held as of April 1, 2025 by the additional employees of the Company who are deemed Participants in our
solicitation of proxies. The Company is unaware of any Participant who owns any securities of the Company of record that such
Participant does not own beneficially, except as described in this proxy statement.

| Name         | Amount and Nature of Beneficial Ownership |
| Andrew Davis | 0 shares of common stock                  |
| Paul Cox     | 185 shares of common stock                |

Information Regarding Transactions in the Company’s Securities by Participants - Last Two Years

The following table sets